You are here

Approvals, Launches, and New Indications

Novel clinical trial endpoint, metastasis-free survival, was used in evaluation
Quick testing option may help reduce CT scans, radiation exposure
FDA permits marketing of Viz.AI Contact to speed treatment
Manufacturing problems caused million-dollar delay
With extended-release dexamethasone, patients can avoid weeks of drops
Gilead tablet contains bictegravir, emtricitabine, and tenofovir alafenamide
New FDA indication comes in combination with prednisone
Moderate-to-severe scalp psoriasis is difficult to treat
Wearable device identifies convulsive epileptic seizures and sends alerts to caregivers